Understanding Pancreatic Cancer
Pancreatic cancer is one of the more challenging cancers to diagnose and treat. It often develops without obvious early symptoms, and many cases are discovered only after the disease has advanced.
However, earlier diagnosis, improved treatments, genetic testing, and ongoing research are creating new opportunities for some patients.
What Is Pancreatic Cancer?
The pancreas is an organ located behind the stomach. It has two important functions:
Producing digestive enzymes that help break down food.
Producing hormones, including insulin, that regulate blood sugar.
Most pancreatic cancers begin in cells that produce digestive enzymes. These cancers are called pancreatic ductal adenocarcinomas.
Less commonly, tumors develop in the hormone-producing cells of the pancreas. These pancreatic neuroendocrine tumors behave differently and often require different treatments.
Why Is Pancreatic Cancer Difficult to Detect?
Early pancreatic cancer often causes few symptoms. When symptoms appear, they may include unexplained weight loss, abdominal or back pain, loss of appetite, fatigue, or yellowing of the skin and eyes (jaundice).
There is currently no recommended routine screening test for people at average risk.
However, people with certain inherited genetic changes or a strong family history may benefit from specialized screening programs.
What About Treatment?
Treatment depends on how far the cancer has progressed, whether surgery is possible, and the patient's overall health.
Surgery offers the possibility of long-term survival for some patients. Chemotherapy, radiation, targeted treatments, and clinical trials may also play important roles.
For older adults, treatment decisions should consider not only survival but also physical function, quality of life, and personal preferences.
What About Metabolic Health?
Diabetes, obesity, and insulin resistance are associated with pancreatic cancer risk.
Researchers are studying how metabolism influences cancer development and treatment. However, there is not yet convincing evidence that low-carbohydrate diets, ketogenic diets, or other metabolic therapies can treat pancreatic cancer.
These approaches should not replace established cancer treatments.